Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-17 · accession 0000899243-22-018862 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-19 | 2022-05-17+ | CORT | Robb Gary Charles | Chief Business Off | S - Sale | $19.55 | -35.0K | 42.6K | -45% | -$684.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-19 | S | D | 6,127 | $19.57 | 36,446 | D | — | — | (F1) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $19.55 to $19.63. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. |
| 2 | Common | Common Stock | 2022-05-17 | S | D | 28,745 | $19.55 | 42,701 | D | — | — | |
| 3 | Common | Common Stock | 2022-05-18 | S | D | 128 | $19.55 | 42,573 | D | — | — |